PATENT CLAIM ANALYSIS

Application Number: 16375745
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-07
Patent Classification: ["424", "181100"]

Abstract:
Methods for the treatment of CD30-expressing cancers are provided. The methods comprise administering to a subject in need thereof a weekly dose of from about 0.8 mg/kg to about 1.8 mg/kg of an antibody-drug conjugate compound having formula (I); or a pharmaceutically acceptable salt thereof; wherein: mAb is an anti-CD30 antibody unit, S is a sulfur atom of the antibody, A− is a Stretcher unit, and p is from about 3 to about 5.

Claim (Index 49):
The method of  claim 30 , wherein the subject has previously undergone a stem cell transplant for treatment of the CD30-expressing hematologic cancer.

Metadata:
- Claim Count in Document: 89.0
- Percentile: 100.0
- Lexical Diversity: 1.44828
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15622496', '14938658', '13143338', '12681599', '12985687']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7236867233899302
- 35 USC 102 Novelty (BERT): 0.5529748207824253
- Combined Prediction Score: 0.7066155331291797
- Mean Citation Score: 309.117316
- Max Citation Score: 404.92755
- Similarity Product: 305.276059150672

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test